vaccine

Anheuser-Busch Pulls Budweiser Super Bowl Ads
Strategy

Anheuser-Busch Pulls Budweiser Super Bowl Ads

The beer giant said it would redirect funds to vaccine outreach.
By Lauren Muskett | January 26, 2021
Read More
AMC Raises $917 Million to Keep Theaters Open
Credit & Capital

AMC Raises $917 Million to Keep Theaters Open

The new equity and debt capital "means that any talk of an imminent bankruptcy for AMC is completely off the table."
By Matthew Heller | January 26, 2021
Read More
Merck Drops Out of COVID-19 Vaccine Race
Risk & Compliance

Merck Drops Out of COVID-19 Vaccine Race

Merck's announcement that it is shelving its two vaccine candidates "marks a shocking setback for one of the most storied vaccine makers."
By Matthew Heller | January 25, 2021
Read More
United Airlines CEO Backs Vaccine Mandate for Workers
Human Capital & Careers

United Airlines CEO Backs Vaccine Mandate for Workers

"I think the right thing to do is for United Airlines, and for other companies, to require [COVID] vaccines."
By Matthew Heller | January 22, 2021
Read More
U.S. Loses 140,000 Jobs Amid New Lockdowns
The Economy

U.S. Loses 140,000 Jobs Amid New Lockdowns

The December jobs report shows "the economy’s not just tapping on the brakes, but actually has been thrown into reverse."
By Matthew Heller | January 8, 2021
Read More
Moderna Q3 Revenues Beat Estimates
Financial Performance

Moderna Q3 Revenues Beat Estimates

The biotech is preparing for the global launch of its potential COVID-19 vaccine.
By Lauren Muskett | October 29, 2020
Read More
Be Ready to Distribute COVID-19 Vaccine in Two Months, CDC Says
Risk & Compliance

Be Ready to Distribute COVID-19 Vaccine in Two Months, CDC Says

Public health authorities were notified to prepare to distribute a coronavirus vaccine as early as late October.
By Lauren Muskett | September 3, 2020
Read More
AstraZeneca Inks COVID-19 Vaccine Supply Deal
M&A

AstraZeneca Inks COVID-19 Vaccine Supply Deal

The pharma giant agreed to pay Oxford Biomedica $20 million to reserve 1,000 liters of production capacity.
By Lauren Muskett | September 1, 2020
Read More
Pfizer, BioNTech to Supply U.S. Government Up to 600M Doses of Coronavirus Vaccine
Risk & Compliance

Pfizer, BioNTech to Supply U.S. Government Up to 600M Doses of Coronavirus Vaccine

The initial 100 million doses ordered is valued at $1.95 billion.
By Lauren Muskett | July 22, 2020
Read More
J&J Speeds Up Timeline for Coronavirus Vaccine
Risk & Compliance

J&J Speeds Up Timeline for Coronavirus Vaccine

After lagging behind other companies, J&J now expects to begin a late-stage study of its vaccine candidate in September.
By Matthew Heller | July 16, 2020
Read More
Merck Enters Race to Develop COVID Vaccine
M&A

Merck Enters Race to Develop COVID Vaccine

The world's largest vaccine maker is no longer on the COVID sidelines after acquiring an Austrian biotech and teaming up with a nonprofit.
By Matthew Heller | May 26, 2020
Read More
Moderna Stock Soars on COVID Vaccine Results
Risk & Compliance

Moderna Stock Soars on COVID Vaccine Results

Interim data from a Phase 1 study showed Moderna's vaccine candidate stimulated an immune response against the virus in people.
By Matthew Heller | May 18, 2020
Read More
Moderna Gets $483M to Fund Corona Vaccine
Risk & Compliance

Moderna Gets $483M to Fund Corona Vaccine

The grant from the U.S. government will boost Moderna's efforts to develop what is “among the most advanced coronavirus vaccine candidates.”
By Matthew Heller | April 17, 2020
Read More